Thermogenesis Holdings Inc
F:THR

Watchlist Manager
Thermogenesis Holdings Inc Logo
Thermogenesis Holdings Inc
F:THR
Watchlist
Price: 1.62 EUR
Market Cap: 4m EUR

Thermogenesis Holdings Inc
PP&E Net

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Thermogenesis Holdings Inc
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Thermogenesis Holdings Inc
F:THR
PP&E Net
$5.5m
CAGR 3-Years
39%
CAGR 5-Years
10%
CAGR 10-Years
9%
Becton Dickinson and Co
NYSE:BDX
PP&E Net
$7B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
6%
Boston Scientific Corp
NYSE:BSX
PP&E Net
$4.3B
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
PP&E Net
$3.7B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
13%
Abbott Laboratories
NYSE:ABT
PP&E Net
$11.5B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
PP&E Net
$5.2B
CAGR 3-Years
32%
CAGR 5-Years
28%
CAGR 10-Years
28%
No Stocks Found

Thermogenesis Holdings Inc
Glance View

Market Cap
4m EUR
Industry
Health Care

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 39 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for large scale cell manufacturing services. The company manufactures and markets three categories of products, Clinical Bio-Banking Applications, Point-of-Care Applications, and Large Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications includes AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Point-of-Care Applications includes PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory useand CAR-TXpress Platform for clinical manufacturing.

THR Intrinsic Value
Not Available

See Also

What is Thermogenesis Holdings Inc's PP&E Net?
PP&E Net
5.5m USD

Based on the financial report for Mar 31, 2024, Thermogenesis Holdings Inc's PP&E Net amounts to 5.5m USD.

What is Thermogenesis Holdings Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
9%

Over the last year, the PP&E Net growth was -4%. The average annual PP&E Net growth rates for Thermogenesis Holdings Inc have been 39% over the past three years , 10% over the past five years , and 9% over the past ten years .

Back to Top